pharma · Breast Cancer · Lumbosacral Radicular Pain · SMNR
Semnur Pharmaceuticals
Semnur Pharmaceuticals is a pharma organization headquartered in Palo Alto, USA. It trades on NYSE under ticker SMNR. Primary therapeutic focus areas include Breast Cancer, Lumbosacral Radicular Pain. NovaPharmaNews link
Palo Alto, USA HQ
2013 Founded
9 Employees
Public company Type
SMNR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Palo Alto, USA
- Founded
- 2013
- Employees
- 9
- Programs
- 2
- Drugs
- 2
- Patents
- 8
Ixabepilone + Capecitabine
Phase 3 · small molecule · Breast Cancer
Ixabepilone + Capecitabine for Breast Cancer is a Phase 3 program (small_molecule) at Semnur Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code CA163-046
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Semnur Pharmaceuticals
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Breast Cancer
- Status
- completed
- Trials
- 1